✦ LIBER ✦

Docetaxel in Second-Line Treatment of non—small-Cell Lung Cancer

✍ Scribed by Frank V. Fossella

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III trial comparing paclitaxel pol

✍ Paz-Ares, L; Ross, H; O'Brien, M; Riviere, A; Gatzemeier, U; Von Pawel, J; Kauke 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

PCN6: MODELLING THE COST-EFFECTIVENESS O

✍ P Sharplin; UK Bose; J Holmes 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

A Randomized Phase II Trial of Oral Topo

✍ Suzanne Jones; Dana Thompson; John Barton; Jeff Patton; Dianna Shipley; F. Antho 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 124 KB

Efficacy and tolerability of docetaxel a

✍ Micallef, R.A.; Birch, E.; Baker, J.; Brewster, A.; Hanna, L.; Lester, J.F.; Lin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 41 KB

PCN90 Cost-Effectiveness Analysis of Erl

✍ Nguyen, T.T.T.; Yagudina, R.; Kulikov, A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

P-526 Phase I/II study of GTI-2040 plus

✍ Leighl, N.; Laurie, S.; Knox, J.; Ellis, P.; Shepherd, F.; Burkes, R.; Pond, G.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 286 KB